Kimberly Manhard

Track

Insider profile

Currently holds positions in Heron Therapeutics Inc and Ardea Biosciences Inc

Performance

Overall performance
3.0
Performance over holding periods
3.0
30 days 90 days 120 days
Average return 11% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Vice President - Drug Development, Director Heron Therapeutics Inc Oct. 1, 2019 -
Senior Vice President - Regulatory Affairs and Development Operations Ardea Biosciences Inc Dec. 21, 2006 -
Executive Vice President - Drug Development Heron Therapeutics Inc Jan. 27, 2016 - Oct. 1, 2019
Independent Director Heron Therapeutics Inc Jan. 10, 2014 - Jan. 27, 2016
Kimberly Manhard's trades of Inhibrx Biosciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-30 2024-08-28
B Purchase
40,407 -13.9%
322.24
US$3,568,671 		40,407 -13.9% 322.24 US$3,568,671
2022-05-04 2022-05-03
PlS Planned sale
78,935 -38.2%
334.66
US$4,130,834 		78,935 -38.2% 334.66 US$4,130,834
2020-12-23 2020-12-22
PlS Planned sale
94,605 -31.4%
281.55
US$4,128,904 		94,605 -31.4% 281.55 US$4,128,904
2020-05-01 2020-05-01
PlS Planned sale
1,158 -100.0%
13.97
US$16,176 		1,158 -100.0% 13.97 US$16,176
2019-05-02 2019-05-01
PlS Planned sale
1,109 -100.0%
18.86
US$20,918 		1,109 -100.0% 18.86 US$20,918